Triumeq PD

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 49702-258
  • Package NDC 49702-258-37
  • Application number NDA215413
  • SPL ID 4018a8c7-db0d-481e-b50a-a469ba32ec4b
  • SPL set ID 2997739a-aa91-42aa-a206-a70e2db7b84f
  • UNII J220T4J9Q2
  • UNII 1Q1V9V5WYQ
  • UNII 2T8Q726O95
  • RxCUI 1546888
  • RxCUI 1546894
  • RxCUI 2598348
  • RxCUI 2598352

What the source publishes

Labeler
ViiV Healthcare Company
Active ingredients
abacavir sulfate, dolutegravir sodium, lamivudine
Form
KIT
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:49702-258_4018a8c7-db0d-481e-b50a-a469ba32ec4b
{
  "name": "Triumeq PD",
  "splId": "4018a8c7-db0d-481e-b50a-a469ba32ec4b",
  "labels": [
    {
      "setId": "2997739a-aa91-42aa-a206-a70e2db7b84f",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2997739a-aa91-42aa-a206-a70e2db7b84f",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2997739a-aa91-42aa-a206-a70e2db7b84f"
    }
  ],
  "routes": [],
  "labeler": "ViiV Healthcare Company",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 KIT in 1 CARTON (49702-258-37)  *  90 TABLET, FILM COATED in 1 BOTTLE (49702-272-59)",
      "package_ndc": "49702-258-37",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220330"
    }
  ],
  "productId": "49702-258_4018a8c7-db0d-481e-b50a-a469ba32ec4b",
  "useDomain": "unknown",
  "dosageForm": "KIT",
  "productNdc": "49702-258",
  "deaSchedule": null,
  "genericName": "abacavir sulfate, dolutegravir sodium, lamivudine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [],
  "applicationNumber": "NDA215413",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20220330",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175656",
      "N0000175462",
      "N0000009947"
    ],
    "upc": [
      "0349702231139"
    ],
    "unii": [
      "J220T4J9Q2",
      "1Q1V9V5WYQ",
      "2T8Q726O95"
    ],
    "rxcui": [
      "1546888",
      "1546894",
      "2598348",
      "2598352"
    ],
    "spl_set_id": [
      "2997739a-aa91-42aa-a206-a70e2db7b84f"
    ],
    "pharm_class_epc": [
      "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
      "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "ViiV Healthcare Company"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:49702-258_4018a8c7-db0d-481e-b50a-a469ba32ec4b"